Literature DB >> 26453305

TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression.

Xiuwen Wang1, Jing Yang2, Lei Han1, Kaixia Zhao1, Qingsi Wu3, Liming Bao4, Zhiyuan Li2, Ling Lv5, Bin Li6.   

Abstract

Retinoid-related orphan nuclear receptor γt (RORγt) is a key transcription factor for the development and function of Th17 cells. In this study, we show that tumor necrosis factor receptor-associated factor 5 (TRAF5), known as an E3 ubiquitin protein ligase and signal transducer, interacts with and ubiquitinates RORγt via Lys-63-linked polyubiquitination. TRAF5 stabilizes the RORγt protein level depending on its RING finger domain. Depletion of TRAF5 in Th17 cells destabilizes RORγt protein and down-regulates Th17-related genes, including IL-17A, an inflammatory cytokine involved in pathogenic mechanisms of several autoimmune diseases such as systemic lupus erythematosus. Moreover, up-regulation of the TRAF5 mRNA level was found in systemic lupus erythematosus patient CD4(+) T cells. Our findings reveal a direct link between TRAF5-mediated ubiquitination and RORγt protein regulation, which may aggravate inflammatory progress and provide new therapeutic drug targets for autoimmune diseases.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RORγt; T helper cells; TNF receptor-associated factor (TRAF); autoimmune disease; transcription factor; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 26453305      PMCID: PMC4661420          DOI: 10.1074/jbc.M115.664573

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

2.  Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation.

Authors:  S Kawamata; T Hori; A Imura; A Takaori-Kondo; T Uchiyama
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

Authors:  Jeanne E McKeon; Di Sha; Lian Li; Lih-Shen Chin
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

5.  Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells.

Authors:  Edward M Esparza; Tullia Lindsten; Julia M Stockhausen; Robert H Arch
Journal:  J Biol Chem       Date:  2006-02-01       Impact factor: 5.157

6.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.

Authors:  Shu Zhu; Wen Pan; Peiqing Shi; Hanchao Gao; Fang Zhao; Xinyang Song; Yan Liu; Lihua Zhao; Xiaoxia Li; Yufang Shi; Youcun Qian
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

7.  Investigation of association between the TRAF family genes and RA susceptibility.

Authors:  Catherine Potter; Stephen Eyre; Andrew Cope; Jane Worthington; Anne Barton
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

8.  USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

Authors:  Xikui Liu; Hongxiu Li; Bo Zhong; Marzenna Blonska; Sara Gorjestani; Ming Yan; Qiang Tian; Dong-Er Zhang; Xin Lin; Chen Dong
Journal:  J Exp Med       Date:  2013-07-01       Impact factor: 14.307

9.  Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.

Authors:  Jun Shen; Yu-qi Qiao; Zhi-hua Ran; Tian-rong Wang
Journal:  Int J Med Sci       Date:  2013-01-03       Impact factor: 3.738

10.  Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25.

Authors:  Bo Zhong; Xikui Liu; Xiaohu Wang; Seon Hee Chang; Xindong Liu; Aibo Wang; Joseph M Reynolds; Chen Dong
Journal:  Nat Immunol       Date:  2012-10-07       Impact factor: 25.606

View more
  21 in total

1.  Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.

Authors:  Zhiheng He; Fei Wang; Jian Ma; Subha Sen; Jing Zhang; Yousang Gwack; Yu Zhou; Zuoming Sun
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

2.  Regulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt.

Authors:  Zhiheng He; Fei Wang; Jing Zhang; Subha Sen; Qihua Pang; Shengwei Luo; Yousang Gwack; Zuoming Sun
Journal:  J Immunol       Date:  2017-06-30       Impact factor: 5.422

3.  The Itch to degrade ROR-γt.

Authors:  Sascha Rutz; Wenjun Ouyang
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

Review 4.  RORγt protein modifications and IL-17-mediated inflammation.

Authors:  Ritesh Kumar; Arianne L Theiss; K Venuprasad
Journal:  Trends Immunol       Date:  2021-10-09       Impact factor: 16.687

Review 5.  (Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.

Authors:  Anton M Jetten; Donald N Cook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-08-06       Impact factor: 13.820

6.  Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.

Authors:  Fuxiang Zhu; Gang Yi; Xu Liu; Fangming Zhu; Anna Zhao; Aiting Wang; Ruihong Zhu; Zuojia Chen; Binbin Zhao; Sijie Fang; Xiao Yu; Ruirong Lin; Rui Liang; Dan Li; Wenyi Zhao; Zizhen Zhang; Wenzhi Guo; Shuijun Zhang; Shengfang Ge; Xianqun Fan; Gang Zhao; Bin Li
Journal:  J Biol Chem       Date:  2018-11-02       Impact factor: 5.157

7.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

Review 8.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

9.  Single nucleotide polymorphisms of TRAF2 and TRAF5 gene in ankylosing spondylitis: a case-control study.

Authors:  Shanshan Xu; Jiangping Kong; Li Huang; Huimin Xie; Feier Wang; Tingting Zhou; Xiaoyi Zhang; Lingxiang Yu; Shengqian Xu; Faming Pan
Journal:  Clin Exp Med       Date:  2021-05-17       Impact factor: 3.984

10.  Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study.

Authors:  Shanshan Xu; Xing Gao; Yubo Ma; Jixiang Deng; Shengqian Xu; Faming Pan
Journal:  Genes Immun       Date:  2021-05-21       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.